European Patent Office

T 0725/05 (Humanized Immunoglobulins II/PDL) of 14.10.2009

European Case Law Identifier
ECLI:EP:BA:2009:T072505.20091014
Date of decision
14 October 2009
Case number
T 0725/05
Petition for review of
-
Application number
95105609.2
IPC class
C07K 16/46
Language of proceedings
English
Distribution
Distributed to board chairmen (C)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
Production of Humanized Immunoglobulins and Corresponding Polynucleotiodies
Applicant name
PDL BioPharma, Inc.
Opponent name
(02) Boehringer Ingelheim GmbH
(03) Medimmune, Inc.
(04) Schering Corporation
(05) CELLTECH R & D LIMITED
(06) XOMA(US)LLC
(07) Novartis AG
(08) IDEC Pharmaceuticals Corpn
Board
3.3.04
Headnote
-
Relevant legal provisions
European Patent Convention Art 111(1)European Patent Convention Art 112European Patent Convention Art 114(1)European Patent Convention Art 76(1)European Patent Convention R 103(1)(a)Rules of procedure of the Boards of Appeal Art 12Rules of procedure of the Boards of Appeal Art 13
Keywords
Substantial procedural violation, remittal, reimbursement of the appeal fee, referral of questions to the EBA - (no)
First auxiliary request - added subject-matter - (yes)
Second auxiliary request - admissibility - (no)
Catchword
-

ORDER

For these reasons it is decided that:

The appeal is dismissed.